Breaking News
August 15, 2018 - ‘Zombie’ gene protects elephants from cancer, study finds
August 15, 2018 - Ebola outbreak in Congo spreads to active combat zone
August 15, 2018 - Study highlights pollution exposure of babies in prams
August 15, 2018 - Study provides insight into link between sleep apnea and lipid metabolism
August 15, 2018 - New study focuses on promise of gene therapy for Amish nemaline myopathy
August 15, 2018 - Researchers discover new approach to alleviate chronic itch
August 15, 2018 - Uncovering the Mysteries of MS: Medical Imaging Helps NIH Researchers Understand the Tricky Disease
August 15, 2018 - Autistic people at greater risk of becoming homeless – new research
August 15, 2018 - New imaging technique can spot tuberculosis infection in an hour
August 15, 2018 - Scientists study effects of eating breakfast versus fasting overnight before exercise
August 15, 2018 - Talking with children about suicide could save lives
August 15, 2018 - Grip strength of children predicts future cardiometabolic health
August 15, 2018 - Innovative oncofertility program launched by RMA of New York and Mount Sinai Health System
August 15, 2018 - Simple score helps predict which hospitalized heart attack patients are at high risk of readmissions
August 15, 2018 - Study shows impact of optimizing airport flight patterns on human health
August 15, 2018 - Life experiences of feeling unwanted or unplanned associated with attachment insecurity
August 15, 2018 - ACS Briefing Discusses Use of Lessons From Combat Care
August 15, 2018 - Study identifies distinct origin of ADHD in children with history of brain injury
August 15, 2018 - IgG3 antibody stops B cells from fighting pathogens in HIV patients
August 15, 2018 - Scientists discover key vulnerability of mixed lineage leukemia
August 15, 2018 - College students may experience pressures from secondary exposure to opioid abuse
August 15, 2018 - Powerful new microscope reveals inner workings of human cells with unprecedented clarity
August 15, 2018 - Married people who fight nastily more likely to suffer from leaky guts, study suggests
August 15, 2018 - Working Out After Baby – Drugs.com MedNews
August 15, 2018 - Rheumatoid Factor (RF) Test: MedlinePlus Lab Test Information
August 15, 2018 - ADHD linked to an increased risk of injury in children, study finds
August 15, 2018 - UIC researchers receive NIH funding to develop a better way to regenerate bone or tissues
August 15, 2018 - Study reveals how immune cells in the brain influence sexual behavior
August 15, 2018 - Researchers move closer to finding potential soft spot in drug-resistant tuberculosis
August 15, 2018 - Real-time dynamic monitoring of cell’s nucleus for effective cancer screening
August 15, 2018 - Lower rates of Medicare preventive care visits found in racial, ethnic minority older adults
August 15, 2018 - Scientists identify stress hormone as key factor in failure of immune system to inhibit leukemia
August 15, 2018 - Cytoplan introduces three new nutritional supplements
August 15, 2018 - Effective hemorrhage control critical for survival after motorsport accidents
August 15, 2018 - Sygnature Discovery announces ambitious expansion plan with addition of Alderley Park facility
August 15, 2018 - Dietary carbohydrates could lead to osteoarthritis, new study finds
August 15, 2018 - Male tobacco smokers have decreased number of cannabinoid CB1 receptors, study reveals
August 15, 2018 - Scientists explore ways for drug therapies to reach deadly brain tumors
August 15, 2018 - Rethinking fundamental rule of stroke care: ‘Time is brain!’
August 15, 2018 - Scientists reveal role of ‘junk DNA’ in cancer dissemination
August 15, 2018 - Google’s DeepMind AI could soon be diagnosing eye conditions
August 15, 2018 - Scientists trick the brain to embody the prosthetic limb
August 15, 2018 - Researchers focus on uncoupling obesity from diabetes
August 15, 2018 - Clinical study shows how EarlySense system effectively detects opioid-induced respiratory depression
August 15, 2018 - A class of proteins shown to be effective in reducing drug-seeking behaviors
August 15, 2018 - FundamentalVR launches first-of-its-kind SaaS software platform for surgical simulation
August 15, 2018 - Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
August 15, 2018 - Rheumatoid arthritis in pregnancy associated with low birth weight and premature birth
August 15, 2018 - Study may help increase effectiveness of antibiotics against drug-resistant bacteria
August 15, 2018 - Analyzing resident-to-resident incidents in dementia may hold the key to reducing future fatalities
August 15, 2018 - Robotic walking frame aims to help maintain mobility of older adults
August 15, 2018 - Simple intervention during routine care reduces alcohol consumption in men with HIV
August 15, 2018 - Genetics Home Reference: gout
August 15, 2018 - Scientists ID genesis of disease, focus efforts on shape-shifting tau
August 15, 2018 - OncoThira and NDSU enter into license agreement to develop, market cancer compounds
August 15, 2018 - Scientists unravel the mystery behind ovarian cancer with high-grade serous carcinoma
August 15, 2018 - Common signs that indicate vision problems in children
August 15, 2018 - Removing the cancer label – overhaul in cancer classification proposed
August 15, 2018 - Prams may expose babies and toddlers to more air pollution finds study
August 15, 2018 - Duke researchers track missing T-cells in glioblastoma patients
August 15, 2018 - Cardiac Profiles Up With Exercise, Less Sitting in Early Old Age
August 15, 2018 - Precision medicine offers a glimmer of hope for Alzheimer’s disease
August 15, 2018 - Immunovia’s new blood-based testing platform accurately detects non-small cell lung cancer
August 15, 2018 - New method provides a ‘big picture’ of genetic influences on traits and diseases
August 15, 2018 - Early Onset Type 1 Diabetes Linked to Heart Disease, Shorter Life
August 14, 2018 - SMURF1 provides targeted approach to preventing cocaine addiction relapse
August 14, 2018 - Genetic testing pushed for hereditary high cholesterol disease
August 14, 2018 - Researchers discover new genes involved in Alzheimer’s Disease
August 14, 2018 - Medicare to overhaul ACOs but critics fear fewer participants
August 14, 2018 - Adolescent health projects receive meager percentage of global funding, study finds
August 14, 2018 - University Hospitals Seidman Cancer Center launches new CAR-T therapy trial
August 14, 2018 - In the addiction battle, is forced rehab the solution?
August 14, 2018 - Busting myths about milk – Scope
August 14, 2018 - Platelet-rich plasma does not enhance cartilage formation capabilities of stem cells
August 14, 2018 - Wearable devices and ‘mhealth’ technology emerge as promising tools for better health
August 14, 2018 - Johns Hopkins expert panel develops first set of operation-specific opioid prescribing guidelines
August 14, 2018 - Clinical study suggests new treatment direction for head and neck cancer in heavy smokers
August 14, 2018 - Phase 2 Clinical Data Published Showing Summit’s Ridinilazole Preserved Gut Microbiome of Patients with CDI
August 14, 2018 - Cardiac progenitor cells undergo a cell fate switch to build coronary arteries
August 14, 2018 - Study identifies potential guidance to treat gastric cancer patients
Interfering with enzyme’s movement may be new approach for developing of anti-cancer drugs

Interfering with enzyme’s movement may be new approach for developing of anti-cancer drugs

image_pdfDownload PDFimage_print

Revealing all the steps required to activate an enzyme called a protein kinase may identify new ways to target cancer, according to new University of Arizona-led research.

Not only must the kinase have all needed parts in place, the enzyme must move in the correct manner and at the correct speed to function properly in a cell, the researchers found.

First author Senthil Kumar Ganesan, a UA research assistant professor of chemistry and biochemistry, said kinases are switches that turn certain cellular processes on or off. If a cell’s kinases stopped working, the cell would die.

The UA-led team is the first group to figure out the full pathway for activating a protein kinase, said senior author Wolfgang Peti, who holds the Homer C. and Emily Davis Weed Endowed Chair in Chemistry at the University of Arizona.

“Kinases are one of the major cancer drug targets,” said Peti, who is also a member of the UA BIO5 Institute and the UA Cancer Center. “If you know how a kinase works, you can definitely better design your drugs against it.”

Developing a drug that takes advantage of this new research finding is likely to take at least 10 years, he said.

Cancer drugs already in use that target kinases are dasatinib and imatinib for chronic myeloid leukemia and afatinib for non-small cell lung carcinoma, Ganesan said.

To watch a kinase called mitogen-activated protein kinase (MAPK) p38 in action, the researchers used nuclear magnetic resonance (NMR) spectroscopy.

All necessary molecules had to bind to p38 for the enzyme to become active. Only then could the enzyme move correctly to do its job in the cell, the researchers found.

“We figured out how it moves to do its job and what is the contribution of speed of movement to its job,” Peti said.

The finding suggests a new avenue for developing anti-cancer drugs could be creating drugs that interfere with p38’s movement, he said.

“We are excited because this kinase belongs to a family of kinases that are called MAP kinases — key signaling kinases that regulate a plethora of pathways (within cells),” he said.

Peti said the new finding might apply to other kinases. He said the many kinase enzymes in the body are very similar and likely have similar paths to activation.

Ganesan, Peti and their co-authors published the paper, “Dynamic activation and regulation of the mitogen-activated protein kinase p38,” in the May 1 issue of the Proceedings of the National Academy of Sciences.

Their co-authors are Michael W. Clarkson and Rebecca Page of the University of Arizona; Micha B. A. Kunze, Daniele Granata and Kresten Lindorff-Larsen of the University of Copenhagen in Denmark; and A. Joshua Wand of the University of Pennsylvania in Philadelphia.

The National Institutes of Health grant NIH-R01GM100910 funded the research. The data were collected at the UA Molecular Structures Core and Brown University Structural Biology Core facilities.

An oft-used analogy for how enzymes work is that of a lock and a key. A particular molecule, the key, fits into a site in the enzyme, the lock. Once the key is in the lock, the enzyme can start working.

The key-in-the-lock is necessary for an enzyme to work, but activating an enzyme isn’t always so simple. Some scientists have suggested that dynamics — the way and speed at which an enzyme moves — is important for activating kinase enzymes.

Peti is interested in how molecules such as kinases govern processes with cells, so he wanted to investigate the role that dynamics play. Learning more about how molecules function inside cells can help develop targeted drugs to combat cancer and other diseases.

Figuring out the role that dynamics plays in the activation of p38 was more difficult and took longer than he expected.

The tool scientists use to watch an enzyme in action, NMR spectroscopy, is harder with a large molecule like p38. In addition, the team had to develop new computer software to analyze the results, Peti said.

The researchers watched the enzyme over a series of steps as various key molecules bound to p38. Some enzymes become activated as key molecules bind — but not this one.

“If you think it’s a five- or six-step process to go from zero to 100, we thought that at steps zero, one, two or three, we would get indications or guidelines,” Peti said.

That didn’t happen. He said the researchers thought about giving up.

“Nothing was working, and it looked as if our hypothesis was completely wrong,” he said.

“What we got is nothing happening from zero to one, there’s nothing happening from one to two, there’s nothing happening from two to three, there’s nothing happening from three to four,” Peti said. “When you go from four to five: Boom! Suddenly it was there.”

Once all those steps had been completed, although the shape of p38 didn’t change, its dynamics did, he said — and that final change in dynamics was required for the enzyme to work.

The team’s next step, Peti said, is seeing whether the motion of kinases plays a role in diabetes.

Source:

https://uanews.arizona.edu/story/enzymes-movement-may-be-key-new-cancer-drugs

Tagged with:

About author

Related Articles